Company Overview of Rapidscan Pharma Solutions, Inc.
Rapidscan Pharma Solutions, Inc. develops, manufactures, and sells a pharmacological stress agent. It develops Regadenoson, a pharmacological stress agent that is used in the diagnosis and risk stratification of cardiovascular disease. It has licensed the rights to sell Regadenoson in Europe, Latin America, Japan, Australia, New Zealand, and Israel. The company was founded in 2010 and is based in the United States.
Founded in 2010
Key Executives for Rapidscan Pharma Solutions, Inc.
Similar Private Companies By Industry
|1st Order Pharmaceuticals, Inc.||United States|
|21st Century Animal Health||United States|
|3 Buds' Organics LLC||United States|
|4P Therapeutics LLC||United States|
|60° Pharmaceuticals, LLC||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|The Advertising Council, Inc.||United States|
|Rush University||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Rapidscan Pharma Solutions, Inc., please visit www.rapidscanpharma.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.